Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 02
2021
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,905
-6.56%
|
$642,555
$131.31 P/Share
|
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
6,019
+10.99%
|
-
|
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,450
-11.31%
|
$713,950
$131.31 P/Share
|
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
4,000
-7.66%
|
$524,000
$131.52 P/Share
|
|
Aug 02
2021
|
John R Liddicoat EVP & President of Americas |
BUY
Grant, award, or other acquisition
|
Direct |
3,353
+7.26%
|
-
|
|
Aug 02
2021
|
John R Liddicoat EVP & President of Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,258
-7.62%
|
$426,798
$131.31 P/Share
|
|
Aug 02
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,047
+16.58%
|
-
|
|
Aug 02
2021
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,450
-6.63%
|
$713,950
$131.31 P/Share
|
|
Aug 02
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,162
+7.7%
|
-
|
|
Aug 02
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,839
-8.0%
|
$895,909
$131.31 P/Share
|
|
Aug 02
2021
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
5,486
+14.13%
|
-
|
|
Aug 02
2021
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
2,272
-7.54%
|
$297,632
$131.31 P/Share
|
|
Aug 02
2021
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,657
+9.63%
|
-
|
|
Aug 02
2021
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,997
-11.53%
|
$523,607
$131.31 P/Share
|
|
Aug 02
2021
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
4,419
+9.04%
|
-
|
|
Aug 02
2021
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
3,908
-8.89%
|
$511,948
$131.31 P/Share
|
|
Aug 02
2021
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
5,333
+17.36%
|
-
|
|
Aug 02
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
1,482
-6.88%
|
$194,142
$131.31 P/Share
|
|
Aug 02
2021
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
6,095
+11.53%
|
-
|
|
Aug 02
2021
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
4,897
-10.75%
|
$641,507
$131.31 P/Share
|
|
Jun 28
2021
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,500
-12.31%
|
$1,437,500
$125.29 P/Share
|
|
Jun 28
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+10.96%
|
$632,500
$55.32 P/Share
|
|
Jun 22
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
714
+22.02%
|
-
|
|
Jun 22
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
714
-0.28%
|
-
|
|
Jun 21
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct |
115
-0.53%
|
$14,145
$123.5 P/Share
|
|
Jun 18
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
938
-4.14%
|
$115,374
$123.23 P/Share
|
|
Jun 18
2021
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
1,168
+4.9%
|
$86,432
$74.84 P/Share
|
|
Jun 15
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
605
-0.7%
|
$75,020
$124.47 P/Share
|
|
Jun 01
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct |
2,473
-10.32%
|
$316,544
$128.07 P/Share
|
|
May 28
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
7,355
-23.49%
|
$926,730
$126.59 P/Share
|
|
May 28
2021
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
12,300
+28.2%
|
$578,100
$47.0 P/Share
|
|
May 28
2021
|
John R Liddicoat EVP & President of Americas |
SELL
Open market or private sale
|
Direct |
34,656
-44.89%
|
$4,366,656
$126.65 P/Share
|
|
May 28
2021
|
John R Liddicoat EVP & President of Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
34,656
+10.63%
|
$2,876,448
$83.03 P/Share
|
|
May 03
2021
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+1.28%
|
-
|
|
May 03
2021
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+3.89%
|
-
|
|
May 03
2021
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+9.09%
|
-
|
|
May 03
2021
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+30.89%
|
-
|
|
May 03
2021
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+33.22%
|
-
|
|
May 03
2021
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+5.77%
|
-
|
|
May 03
2021
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+2.25%
|
-
|
|
May 03
2021
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+50.0%
|
-
|
|
May 03
2021
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+11.41%
|
-
|
|
May 03
2021
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+1.9%
|
-
|
|
May 03
2021
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+3.63%
|
-
|
|
Apr 27
2021
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-1.23%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-0.63%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-4.51%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-0.75%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-24.01%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-20.51%
|
$54,954
$129.97 P/Share
|